Search research articles
Contact Us
Filters
Showing results (1-10 of 56) with videos related to
Page
of 6
Sort By:
Neurosurgery
|
August 16, 2012
Comment
Sverre H Torp
Clinical Neuropathology
|
August 25, 2020
On the use of proliferation markers in human meningiomas
Sverre H Torp
Pathology, Research and Practice
|
June 7, 2002
Ki-67 immunoreactivity, basic fibroblastic growth factor (bFGF) expression, and microvessel density as supplementary prognostic tools in low-grade astrocytomas. An immunohistochemical study with special reference to the reliability of different Ki-67 antibodies
Sverre H Torp, Mirjam Alsaker
Journal of Neuro-Oncology
|
November 22, 2016
MCM7 expression is a promising predictor of recurrence in patients surgically resected for meningiomas
Theo L Winther, Sverre H Torp
World Neurosurgery
|
November 22, 2016
Significance of the Extent of Resection in Modern Neurosurgical Practice of World Health Organization Grade I Meningiomas
Theo L Winther, Sverre H Torp
Plos One
|
March 17, 2017
DNA topoisomerase IIα and mitosin expression predict meningioma recurrence better than histopathological grade and MIB-1 after initial surgery
Theo L Winther, Sverre H Torp
Plos One
|
September 28, 2017
The anti-apoptotic protein survivin can improve the prognostication of meningioma patients
Theo L Winther, Sverre H Torp
Diagnostic Pathology
|
May 26, 2011
Evaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisomerase IIα in human anaplastic astrocytomas--an immunohistochemical study
Andreas H Habberstad, Sasha Gulati, Sverre H Torp
International Journal of Clinical and Experimental Pathology
|
May 5, 2012
The histopathological spectrum of human meningiomas
Thomas Backer-Grøndahl, Bjørnar H Moen, Sverre H Torp
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
July 12, 2012
Proliferative activity and histopathological features in diffuse grade II astrocytomas
Tove Lind-Landström, Andreas H Habberstad, Sverre H Torp
Page
of 6
Search research articles
Search
Showing results (1-10 of 56) with videos related to
Sort By:
Page
of 6
Neurosurgery
|
August 16, 2012
Comment
Sverre H Torp
Clinical Neuropathology
|
August 25, 2020
On the use of proliferation markers in human meningiomas
Sverre H Torp
Pathology, Research and Practice
|
June 7, 2002
Ki-67 immunoreactivity, basic fibroblastic growth factor (bFGF) expression, and microvessel density as supplementary prognostic tools in low-grade astrocytomas. An immunohistochemical study with special reference to the reliability of different Ki-67 antibodies
Sverre H Torp, Mirjam Alsaker
Journal of Neuro-Oncology
|
November 22, 2016
MCM7 expression is a promising predictor of recurrence in patients surgically resected for meningiomas
Theo L Winther, Sverre H Torp
World Neurosurgery
|
November 22, 2016
Significance of the Extent of Resection in Modern Neurosurgical Practice of World Health Organization Grade I Meningiomas
Theo L Winther, Sverre H Torp
Plos One
|
March 17, 2017
DNA topoisomerase IIα and mitosin expression predict meningioma recurrence better than histopathological grade and MIB-1 after initial surgery
Theo L Winther, Sverre H Torp
Plos One
|
September 28, 2017
The anti-apoptotic protein survivin can improve the prognostication of meningioma patients
Theo L Winther, Sverre H Torp
Diagnostic Pathology
|
May 26, 2011
Evaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisomerase IIα in human anaplastic astrocytomas--an immunohistochemical study
Andreas H Habberstad, Sasha Gulati, Sverre H Torp
International Journal of Clinical and Experimental Pathology
|
May 5, 2012
The histopathological spectrum of human meningiomas
Thomas Backer-Grøndahl, Bjørnar H Moen, Sverre H Torp
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
July 12, 2012
Proliferative activity and histopathological features in diffuse grade II astrocytomas
Tove Lind-Landström, Andreas H Habberstad, Sverre H Torp
Page
of 6